AI news
Flatiron announces international data for its AI-assisted oncology research tool
Flatiron Health announced an international expansion of Telescope, its AI-powered oncology research platform, drawing on data from the UK, Germany and Japan alongside the US. The company says its underlying database covers more than six million patients and plans to demonstrate the international capabilities at ESMO 2026. The announcement does not establish broad customer access or improved clinical outcomes.
Primary source · Flatiron Health · October 13, 2026
Opens Flatiron Health in a new tab. Read it there before you rely on the summary above.
Read the original
Free, email only
Unlock the full brief free.
- What to check before you trust this story, written down
- Each verified source, with why it matters and who published it
- A note whenever a source has been withdrawn
- Thirty days of stories to browse, not seven
Continuing subscribes the email on that account to Work Worth Doing, my newsletter, the same as the form below, and unlocks every free tool in this browser. We only receive your email address. Unsubscribe in one click.